SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000059478-22-000277
Filing Date
2022-12-13
Accepted
2022-12-13 07:03:51
Documents
15
Period of Report
2022-12-13
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K lly-20221213.htm   iXBRL 8-K 72412
2 EX-99 lly-2023financialguidancep.htm EX-99 64725
7 logoa31a.jpg GRAPHIC 14287
  Complete submission text file 0000059478-22-000277.txt   422688

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20221213.xsd EX-101.SCH 4621
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20221213_def.xml EX-101.DEF 20314
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20221213_lab.xml EX-101.LAB 43455
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20221213_pre.xml EX-101.PRE 21542
9 EXTRACTED XBRL INSTANCE DOCUMENT lly-20221213_htm.xml XML 31389
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 221458529
SIC: 2834 Pharmaceutical Preparations